A New Option After Surgery: FDA Backs Tecentriq Combination for a High-Risk Colon Cancer
For patients whose stage III colon cancer carries a particular genetic signature — a deficiency in DNA mismatch repair, known as dMMR — the…
Top stories, straight to you.
Health news from VIP News Hub: health, medicine and wellbeing with background, context and what to watch next, updated by our editors.
For patients whose stage III colon cancer carries a particular genetic signature — a deficiency in DNA mismatch repair, known as dMMR — the…
Answers come from this site’s published pages. Anything else goes to the team.